Albrecht Terrance L, Eggly Susan S, Gleason Marci E J, Harper Felicity W K, Foster Tanina S, Peterson Amy M, Orom Heather, Penner Louis A, Ruckdeschel John C
Barbara Ann Karmanos Cancer Institute, 4100 John R St, Detroit, MI 48201, USA.
J Clin Oncol. 2008 Jun 1;26(16):2666-73. doi: 10.1200/JCO.2007.14.8114.
To investigate how communication among physicians, patients, and family/companions influences patients' decision making about participation in clinical trials.
We video recorded 235 outpatient interactions occurring among oncologists, patients, and family/companions (if present) at two comprehensive cancer centers. We combined interaction analysis of the real-time video-recorded observations (collected at Time 1) with patient self-reports (Time 2) to determine how communication about trial offers influenced accrual decisions.
Clinical trials were explicitly offered in 20% of the interactions. When offers were made and patients perceived they were offered a trial, 75% of patients assented. Observed messages (at Time 1) directly related to patients' self-reports regarding their decisions (2 weeks later), and how they felt about their decisions and their physicians. Specifically, messages that help build a sense of an alliance (among all parties, including the family/companions), provide support (tangible assistance and reassurance about managing adverse effects), and provide medical content in language that patients and family/companions understand are associated with the patient's decision and decision-making process.
In two urban, National Cancer Institute-designated comprehensive cancer centers, a large percentage of patients are not offered trials. When offered a trial, most patients enroll. The quality and quantity of communication occurring among the oncologist, patient, and family/companion when trials are discussed matter in the patient's decision-making process. These findings can help increase physician awareness of the ways that messages and communication behaviors can be observed and evaluated to improve clinical practice and research.
探讨医生、患者及家属/陪伴者之间的沟通如何影响患者参与临床试验的决策。
我们对两家综合癌症中心肿瘤学家、患者及家属/陪伴者(若有)之间发生的235次门诊互动进行了录像。我们将实时录像观察(在时间1收集)的互动分析与患者自我报告(时间2)相结合,以确定关于试验邀请的沟通如何影响入组决策。
在20%的互动中明确提出了临床试验邀请。当提出邀请且患者认为自己被提供了一项试验时,75%的患者表示同意。观察到的信息(在时间1)与患者关于其决策(两周后)的自我报告直接相关,以及他们对自己的决策和医生的感受。具体而言,有助于建立联盟感(在所有各方,包括家属/陪伴者之间)、提供支持(关于管理不良反应的实际帮助和安慰)以及用患者和家属/陪伴者能理解的语言提供医学内容的信息,与患者的决策及决策过程相关。
在两家由美国国立癌症研究所指定的城市综合癌症中心,很大比例的患者未被提供试验机会。当被提供试验机会时,大多数患者会入组。在讨论试验时,肿瘤学家、患者及家属/陪伴者之间沟通的质量和数量在患者的决策过程中很重要。这些发现有助于提高医生对信息和沟通行为的观察及评估方式的认识,以改善临床实践和研究。